Eugia Pharma signs voluntary license with Medicines Patent Pool to develop generic version of Nilotinib Capsules
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The company will submit its comprehensive response on these observations to the USFDA
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.
Subscribe To Our Newsletter & Stay Updated